4.8 Article

Rates of Cardiac Catheterization Cancelation for ST-Segment Elevation Myocardial Infarction After Activation by Emergency Medical Services or Emergency Physicians Results From the North Carolina Catheterization Laboratory Activation Registry

期刊

CIRCULATION
卷 125, 期 2, 页码 308-313

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.110.007039

关键词

acute myocardial infarction; emergency department; emergency medical services; ST-segment elevation myocardial infarction; systems of care

资金

  1. Blue Cross
  2. Blue Shield of North Carolina
  3. Astellas Pharma US
  4. AstraZeneca
  5. Boehringer Ingelheim
  6. Bristol Myers Squibb
  7. Glaxo SmithKline
  8. Medtronic Foundation
  9. Merck Co.
  10. Sanofi-Aventis
  11. Medicines Company
  12. Hoffmann-La Roche
  13. Novartis Pharmaceutical Company
  14. Otsuka Pharmaceutical and Development & Commercialization, Inc.
  15. Pfizer

向作者/读者索取更多资源

Background-For patients with an acute ST-segment elevation myocardial infarction, cardiac catheterization laboratory (CCL) activation by emergency medical technicians or emergency physicians has been shown to substantially reduce treatment times. One drawback to this approach involves overtriage, whereby CCL staffs are activated for patients who ultimately do not require emergent coronary angiography or for patients who undergo angiography but are not found to have coronary artery occlusion. Methods and Results-We examined CCL activation at 14 primary angioplasty hospitals to determine the course of management, including the rate of inappropriate activation. Among 3973 activations (29% by emergency medical technicians, 71% by emergency physicians) between December 2008 and December 2009, appropriate CCL activations occurred for 3377 patients (85%), with 2598 patients (76.9% of appropriate activations) receiving primary percutaneous coronary intervention. Reasons for inappropriate activations (596 patients; 15%) included ECG reinterpretations (427 patients; 72%) or the fact that the patient was not a CCL candidate (169 patients; 28%). The rate of cancellation because of reinterpretation of emergency medical technicians' ECG (6% of all activations) was more common than for cancellation because of reinterpretation of emergency physicians' ECG (4.6%). Conclusions-This represents the first report of the rates of CCL cancellation for ST-segment elevation myocardial infarction system activation by emergency medical technicians and emergency physicians in a large group of hospitals organized within a statewide program. The high rate of coronary intervention and relatively low rate of inappropriate activation suggest that systematic CCL activation by emergency personnel on a broad scale is feasible and accurate, and these rates set a benchmark for ST-segment elevation myocardial infarction systems. (Circulation. 2012;125:308-313.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据